Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study

Table 1

Baseline characteristics of the patients.

	Denosumab	Control	value
	17	20
Age (years)	72.8 ± 9.5	71.2 ± 11.0	NS
Body mass index (kg/m^2)	21.6 ± 2.3	20.8 ± 2.3	NS
HD duration (years)	7.1 ± 4.9	6.4 ± 5.3	NS
BMD (% of young mean)	56.7 ± 7.2	54.7 ± 11.0	NS

Continuous values are given as mean ± SD. The body mass index is the weight in kilograms divided by the square of the height in meters. BMD: bone mineral density; NS: not significant.